• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


38.4100 USD 0.2500 0.66%

As of 16:30:00 ET on 12/18/2014.

Snapshot for Akorn Inc (AKRX)

Open: 38.7600 Day's Range: 38.0200 - 39.2730 Volume: 867,933
Previous Close: 38.1600 52wk Range: 20.5200 - 45.2500 1-Yr Rtn: +54.01%

Stock Chart for AKRX

No chart data available.
  • AKRX:US 38.4100
  • 1D
  • 1M
  • 1Y
Interactive AKRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKRX

Current P/E Ratio (ttm) 132.8721
Estimated P/E(12/2014) 33.8217
Relative P/E vs. SPX 7.5650
Earnings Per Share (USD) (ttm) 0.2883
Est. EPS (USD) (12/2014) 1.1330
Est. PEG Ratio 1.1683
Market Cap (M USD) 4,130.80
Shares Outstanding (M) 107.83
30 Day Average Volume 1,698,811
Price/Book (mrq) 12.8701
Price/Sale (ttm) 8.4629
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 08/29/1991
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKRX

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for AKRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil